SHARES PLUMMETS AFTER NOVO NORDISK DEAL FAILURE

Shares of HIMS experienced read more a dramatic drop today following the unexpected cancellation of its deal with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending its stock price plummeting by nearly fifteen percent. The reason for the collapse of the partnership remains unclear, but industry analysts speculate t